Perspectives on decisions for treatment and care in severe asthma

Canonica, 2019, Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry, World Allergy Organ J, 12, 100007, 10.1016/j.waojou.2018.12.001 2020 Apps, 2019, Patient perceptions of living with severe asthma: challenges to effective management, J Allergy Clin Immunol Pract, 7, 2613, 10.1016/j.jaip.2019.04.026 Sullivan, 2013, Asthma in USA: its impact on health-related quality of life, J Asthma, 50, 891, 10.3109/02770903.2013.813035 Patel, 2014, Physician-patient communication on cost and affordability in asthma care. Who wants to talk about it and who is actually doing it, Ann Am Thorac Soc, 11, 1538, 10.1513/AnnalsATS.201408-363OC Nunes, 2017, Asthma costs and social impact, Asthma Res Pract, 3, 1, 10.1186/s40733-016-0029-3 Kyriopoulos, 2019, PP127 Asthma patient value framework: lessons from patient focus groups, Int J Technol Assess Health Care, 35, 61, 10.1017/S0266462319002459 Hannane, 2019, Asthma patients' perception on their care pathway: a qualitative study, NPJ Prim Care Respir Med, 29, 9, 10.1038/s41533-019-0121-2 Chung, 2014, International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma, Eur Respir J, 43, 343, 10.1183/09031936.00202013 Price, 2017, Asthma referrals: a key component of asthma management that needs to be addressed, J Asthma Allergy, 10, 209, 10.2147/JAA.S134300 Nielsen, 2009, Involving stakeholders and developing a policy for stakeholder involvement in the European network for health technology assessment, EUnetHTA, Int J Technol Assess Health Care, 25, 84, 10.1017/S0266462309990729 2020 de Silva, 2013 Tapp, 2017, Patient perspectives on engagement in shared decision-making for asthma care, Fam Pract, 34, 353 Menzies-Gow, 2018, A charter to improve patient care in severe asthma, Adv Ther, 35, 1485, 10.1007/s12325-018-0777-y 2016 2016 2016 Calderón, 2017, Information and communication technology use in asthmatic patients: a cross-sectional study in Latin America, ERJ Open Res, 3, 5, 10.1183/23120541.00005-2017 Cappuccio, 2019, Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma, Multidiscip Respir Med, 14, 26, 10.1186/s40248-019-0190-7 Foster, 2017, “I have lost in every facet of my life”: the hidden burden of severe asthma, Eur Respir J, 50, 1700765, 10.1183/13993003.00765-2017 Larenas-Linnemann, 2019, An online survey detected knowledge gaps and cost-saving opportunities in asthma maintenance treatment among allergists, pulmonologists, ENTs and primary care, World Allergy Organ J, 12, 100084, 10.1016/j.waojou.2019.100084 Carranza Rosenzweig, 2004, The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma, Respir Med, 98, 1157, 10.1016/j.rmed.2004.04.001 Farne, 2017, Anti-IL5 therapies for asthma, Cochrane Database Syst Rev, 9, CD010834 Lötvall, 2011, Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome, J Allergy Clin Immunol, 127, 355, 10.1016/j.jaci.2010.11.037 Pahus, 2015, External validity of randomized controlled trials in severe asthma, Am J Respir Crit Care Med, 192, 259, 10.1164/rccm.201502-0391LE Brown, 2018, Randomised controlled trials in severe asthma: selection by phenotype or stereotype, Eur Respir J, 52, 1801444, 10.1183/13993003.01444-2018 Pahus, 2020, Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?, BMC Med Ethics, 21, 72, 10.1186/s12910-020-00509-y Travers, 2007, External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?, Thorax, 62, 219, 10.1136/thx.2006.066837 Thompson, 2013, Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong Kong, Respirology, 18, 957, 10.1111/resp.12137 Lisspers, 2016, Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG, NPJ Prim Care Respir Med, 26, 16016, 10.1038/npjpcrm.2016.16 Roche, 2019, Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology task Force, Clin Transl Allergy, 9, 20, 10.1186/s13601-019-0255-x Mercieca-Bebber, 2018, The importance of patient-reported outcomes in clinical trials and strategies for future optimization, Patient Relat Outcome Meas, 9, 353, 10.2147/PROM.S156279 Vamos, 1999, Psychological factors in severe chronic asthma, Aust N Z J Psychiatry, 33, 538, 10.1080/j.1440-1614.1999.00591.x Sturdy, 2002, Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study, Thorax, 57, 1034, 10.1136/thorax.57.12.1034 Brusselle, 2009, “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study, Respir Med, 103, 1633, 10.1016/j.rmed.2009.06.014 Norman, 2013, Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation, Health Technol Assess, 17, 1, 10.3310/hta17520 Chupp, 2017, Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial, Lancet Respir Med, 5, 390, 10.1016/S2213-2600(17)30125-X Hossny, 2017, Severe asthma and quality of life, World Allergy Organ J, 10, 28, 10.1186/s40413-017-0159-y Luc, 2019, Placebo effects in clinical trials evaluating patients with uncontrolled persistent asthma, Ann Am Thorac Soc, 16, 1124, 10.1513/AnnalsATS.201901-071OC Hyland, 2015, A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales, Qual Life Res, 24, 631, 10.1007/s11136-014-0801-x Peláez, 2016, How can adherence to asthma medication be enhanced? Triangulation of key asthma stakeholders' perspectives, J Asthma, 53, 1076, 10.3109/02770903.2016.1165696 2018 Warner, 2018, EUPATI guidance for patient involvement in medicines research and development (R&D); guidance for pharmaceutical industry-led medicines R&D, Front Med (Lausanne), 5, 270, 10.3389/fmed.2018.00270 2015 Liu, 2013, A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy, Allergy Asthma Clin Immunol, 9, 30, 10.1186/1710-1492-9-30 George, 2015, Urban adults' perceptions of factors influencing asthma control, J Asthma, 52, 98, 10.3109/02770903.2014.947651 Chung, 2020, Rational oral corticosteroid use in adult severe asthma: a narrative review, Respirology, 25, 161, 10.1111/resp.13730 Bourdin, 2020, How can we minimise the use of regular oral corticosteroids in asthma?, Eur Respir Rev, 29, 190085, 10.1183/16000617.0085-2019 Gelhorn, 2019, Patient and physician preferences for attributes of biologic medications for severe asthma, Patient Prefer Adherence, 13, 1253, 10.2147/PPA.S198953 Maspero, 2013, Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America, World Allergy Organ J, 6, 19, 10.1186/1939-4551-6-19 Nathan, 2015, Taking aim at asthma around the world: global results of the asthma insight and management survey in the Asia-Pacific region, Latin America, Europe, Canada, and the United States, J Allergy Clin Immunol Pract, 3, 734, 10.1016/j.jaip.2015.04.013 Boonsawat, 2015, Survey of asthma management in Thailand - the asthma insight and management study, Asian Pac J Allergy Immunol, 33, 14 Katsaounou, 2018, Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma, ERJ Open Res, 4, 10.1183/23120541.00076-2018 Mungan, 2018, Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT program, Respir Med, 139, 55, 10.1016/j.rmed.2018.03.030 Khadadah, 2009, Asthma insights and reality in the Gulf and the near East, Int J Tuberc Lung Dis, 13, 1015 2014 Beharry, 2015, Reality and understanding of asthma control, Chron Respir Dis, 12, 340, 10.1177/1479972315598692 Alzaabi, 2018, Cross-sectional study on asthma insights and management in the Gulf and Russia, Allergy Asthma Proc, 39, 430, 10.2500/aap.2018.39.4180 Lingner, 2017, What patients really think about asthma guidelines: barriers to guideline implementation from the patients' perspective, BMC Pulm Med, 17, 13, 10.1186/s12890-016-0346-6 Doyle, 2013, A systematic review of evidence on the links between patient experience and clinical safety and effectiveness, BMJ Open, 3, 10.1136/bmjopen-2012-001570 Zimmerman, 2005, Psoriatic arthritis and psoriasis: role of patient advocacy organisations in the twenty first century, Ann Rheum Dis, 64, ii93 Kerdel, 2015, An evolution in switching therapy for psoriasis patients who fail to meet treatment goals, Dermatol Ther, 28, 390, 10.1111/dth.12267